Facebook Linkedin Twitter
Inside Precision Medicine YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Leukemia

Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
Oncology

YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Alice McCarthy
0
Tom and Emily whitehead
Multimedia

Not All Precision Medicine Heroes Wear Lab Coats

Jonathan D. Grinstein, PhD
0
Chronic myeloid leukemia cells or CML
News & Features

Terns Pharmaceuticals’ Allosteric Inhibitor Shows “Best-in-Class” Potential in Phase I CML Study

Chris Anderson
0
Acute myeloid leukemia (AML)
Molecular Dx

NIH Launches myeloMATCH Precision Medicine Trials for Myeloid Cancers

0
Lymphocytes and biomedical concept, 3d rendering.
News & Features

First Patient Dosed with In Vivo Gene Therapy for CAR T

Jonathan D. Grinstein, PhD
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

On/Off Switch for CAR-T Cell Therapy Shows Early Promise

0
Destruction of leukaemia cell in blood cancer
Molecular Dx

Certain Pediatric Leukemia Subtypes Can Have Good Outcomes Even with Low-Intensity Therapy 

0
Mother throwing up her Son with Down Syndrome at home
News & Features

Reasons Behind Leukemia Susceptibility in People with Down Syndrome Uncovered

0
Acute myeloid leukemia (AML)
News & Features

MyeloMATCH Plans to Bring Precision Treatments to U.S. Blood Cancer Patients

0
TKI Acalabrutinib molecular structure isolated on white
News & Features

Adding Ruxolitinib to TKI Treatments Enhances Molecular Response in Chronic Myeloid Leukemia

0
123...18Page 1 of 18

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine